| 1 |
1. Pradhan S, Snehlata, Manna D, Karmakar S, Singh MK, Bhattacharya A, Mukherjee B, Paul J, Activation of TLR-pathway to induce host Th1 immune response against visceral leishmaniasis: Involvement of galactosylated-flavonoids, Heliyon, 2022 |
| 2 |
Ghosh S, Biswas S, Mukherjee S, Pal A, Saxena A, Sundar S, Dujardin JC, Das S, Roy S, Mukhopadhyay R, Mukherjee B, A novel bioimpedance based detection of Miltefosine susceptibility among clinical Leishmania donovani isolates of the Indian subcontinent exhibiting resistance to multiple drugs, Front Cell Infect Microbiol, 2021 |
| 3 |
Sharma N, Kashif M, Vigyasa Singh, Fontinha D, Mukherjee B, Kumar D, Singh S, Prudencio M, Agam P Singh AP, Rathi B, Novel Antiplasmodial Compounds Leveraged with Multistage Potency against the Parasite Plasmodium falciparum: In Vitro and In Vivo Evaluations and Pharmacokinetic Studies, J Med Chem, 2021 |
| 4 |
Gaëlle Lentini G, Ben Chaabene R, Vadas O, Ramakrishnan C, Mukherjee B, Mehta V, Lunghi M, Grossmann J, Maco B, Visentin R, Hehl AB, Korkhov VM, Soldati-Favre D, Structural insights into an atypical secretory pathway kinase crucial for Toxoplasma gondii invasion, Nature Communication, 2021 |
| 5 |
Mukherjee S, Pradhan S, Ghosh S, Sundar S, Das S, Mukherjee B, Roy S, Short-Course Treatment with Imipramine Entrapped in Squalene Liposomes Results in Sterile Cure of Experimental Visceral Leishmaniasis Induced by Antimony Resistant Leishmania donovani With Increased Efficacy, Front Cell Infect Microbiol, 2020 |
| 6 |
Mukherjee B*, Mukherjee K, Nanda P, Mukhopadhayay R, Ravichandiran V, Bhattacharyya SN, Roy S, Probing the molecular mechanism of aggressive infection by antimony resistant Leishmania donovani, Cytokine, 2020 |
| 7 |
Mukherjee B., Tessaro F. , Vahokoski J. , Kursula I. , Marq J. , Scapozza L. , Soldati-favre D., Modeling and resistant alleles explain the selectivity of antimalarial compound 49c towards apicomplexan aspartyl proteases, EMBO J, 98047-98062, 2018 |
| 8 |
Dogga S. K., Mukherjee B. , Jacot D. , Malino L. , Hammoudi P. , Hartkoorn R. , Hell A. , Soldat-favre D, A drugable secretory protein maturase of Toxoplasma essential for invasion and egress, Elife, 2017 |
| 9 |
Pino P., Caldelari R. , Mukherjee B. , Vahokoski J. , Klages N. , Maco B. , Collins C. ., Blackman M. J., Kursula I. , Heussler V. , Brochet M. , Soldati-favre D., A multi-stage antimalarial targets the plasmepsins IX and X essential for invasion and egress, Science, 358, 522-528, 2017 |
| 10 |
Mukherjee B., Paul J. , Mukherjee S. , Mukhopadhyay R. , Das S. , Naskar K. , Dujardin J. , Roy S., Antimony-Resistant Leishmania donovani Exploits miR-466i To Deactivate Host MyD88 for Regulating IL-10/IL-12 Levels during Early Hours of Infection, J. Immunol, 195, 2731-2742, 2015 |
| 11 |
Mukherjee S., Mukherjee B. , Mukhopadhyay R. , Naskar K. , Dujardin J. , Roy S, Imipramine exploits Histone deacetylase 11 to increase IL-12/IL-10 ratio in macrophages infected with antimony resistant Leishmania donovani and clears organ parasite in experimental infection, J. Immunol, 193, 4083-4094, 2014 |
| 12 |
Mukherjee B., Mukhopadhyay R. , Bannerjee B. , Chowdhury S. , Naskar K. , Allam U. , Chakravortty D. , Sundar S. , Dujardin J. , Roy S., Antimony resistant Leishmania donovani upregulates IL-10 to overexpress host multi drug resistant protein1, Proc Natl Acad Sci U S A, 110, 575-582, 2013 |
| 13 |
Chowdhury S., Mukherjee T. , Mukhopadhyay R. , Mukherjee B. , Sengupta S. , Chattopadhyay S. , Jaisankar P. , Roy S. , Majumder H., The lignan niranthin poisons Leishmania donovani topoisomerase IB and favours a Th1 immune response in mice, EMBO Mol Med, 1126-1143 (, 2012 |
| 14 |
Mukhopadhyay R., Mukherjee S. , Mukherjee B. , Naskar K. , Mondal D. , Decuypere S. , Ostyn B. , Prajapati V. , Sundar S. , Dujardin J. , Roy S., Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells, Int J Parasitol, 1311-1321, 2011 |
| 15 |
Pradhan S, Ghosh S, Hussain S, Paul J, Mukherjee B, Linking membrane fluidity with defective antigen presentation in leishmaniasis. Parasite Immunol, Parasite Immunol |
